# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 12, "Diabet Med .", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasJournal> \"Diabet Med .\"."
1, PublicationYear, 13, 17, "2017", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasPublicationYear> \"2017\"."
27, Title, 97, 297, "Safety and efficacy of insulin degludec / liraglutide ( IDegLira ) added to sulphonylurea alone or to sulphonylurea and metformin in insulin - na ï ve people with Type 2 diabetes : the DUAL IV trial .", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasTitle> \"Safety and efficacy of insulin degludec / liraglutide ( IDegLira ) added to sulphonylurea alone or to sulphonylurea and metformin in insulin - na ï ve people with Type 2 diabetes : the DUAL IV trial .\"."
2, InsulinDegludec, 120, 136, "insulin degludec", "", 
96037, FixedCombDrug, 128, 150, "degludec / liraglutide", "", 
5, Liraglutide, 139, 150, "liraglutide", "", 
8, FixedCombDrug, 153, 161, "IDegLira", "", 
16, Sulfonylureas, 173, 186, "sulphonylurea", "", 
19, Sulfonylureas, 199, 212, "sulphonylurea", "", 
20, Metformin, 217, 226, "metformin", "", 
26, Precondition, 230, 275, "insulin - na ï ve people with Type 2 diabetes", "", "<http://ctro/data#Population_70066> <http://ctro/data#hasPrecondition> \"insulin - na ï ve people with Type 2 diabetes\"."
22, Type2Diabetes, 260, 275, "Type 2 diabetes", "", "<http://ctro/data#ClinicalTrial_70050> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
28, Author, 298, 308, "Rodbard HW", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Rodbard HW\"."
29, Author, 317, 324, "Bode BW", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Bode BW\"."
30, Author, 333, 342, "Harris SB", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Harris SB\"."
31, Author, 351, 357, "Rose L", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Rose L\"."
32, Author, 366, 375, "Lehmann L", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Lehmann L\"."
33, Author, 384, 392, "Jarlov H", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Jarlov H\"."
34, Author, 401, 410, "Thurman J", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasAuthor> \"Thurman J\"."
35, Liraglutide, 434, 445, "Liraglutide", "", 
36, InsulinDegludec, 450, 466, "insulin degludec", "", 
37, USA, 583, 586, "USA", "", 
38, USA, 640, 643, "USA", "", 
40, Canada, 706, 712, "Canada", "", 
41, Germany, 767, 774, "Germany", "", 
42, Country, 815, 822, "Denmark", "", 
39, USA, 871, 874, "USA", "", 
45, ObjectiveDescription, 883, 1092, "To investigate the safety and efficacy of insulin degludec / liraglutide ( IDegLira ) , a novel combination product , as add - on therapy for people with Type 2 diabetes uncontrolled on sulphonylurea therapy .", "", "<http://ctro/data#ClinicalTrial_70050> <http://ctro/data#hasObjectiveDescription> \"To investigate the safety and efficacy of insulin degludec / liraglutide ( IDegLira ) , a novel combination product , as add - on therapy for people with Type 2 diabetes uncontrolled on sulphonylurea therapy .\"."
3, InsulinDegludec, 925, 941, "insulin degludec", "", 
6, Liraglutide, 944, 955, "liraglutide", "", 
9, FixedCombDrug, 958, 966, "IDegLira", "", 
44, Precondition, 1025, 1090, "people with Type 2 diabetes uncontrolled on sulphonylurea therapy", "", "<http://ctro/data#Population_70066> <http://ctro/data#hasPrecondition> \"people with Type 2 diabetes uncontrolled on sulphonylurea therapy\"."
23, Type2Diabetes, 1037, 1052, "Type 2 diabetes", "", 
43, Sulfonylureas, 1069, 1082, "sulphonylurea", "", 
46, Duration, 1111, 1120, "26 - week", "", "<http://ctro/data#ClinicalTrial_70050> <http://ctro/data#hasCTduration> \"26 - week\"."
47, DoubleBlind, 1123, 1137, "double - blind", "", "<http://ctro/data#ClinicalTrial_70050> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
48, Type2Diabetes, 1158, 1173, "Type 2 diabetes", "", 
49, HbA1c, 1176, 1181, "HbA1c", "", 
151, ConcentrationUnit, 1190, 1200, "mmol / mol", "", 
51, Percentage, 1217, 1218, "%", "", 
52, Randomized, 1228, 1238, "randomized", "", "<http://ctro/data#ClinicalTrial_70050> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
18, FixedCombDrug, 1242, 1250, "IDegLira", "", 
54, NumberPatientsArm, 1257, 1260, "289", "", "<http://ctro/data#Arm_70074> <http://ctro/data#hasNumberPatientsArm> \"289\"."
56, Placebo, 1266, 1273, "placebo", "", "<http://ctro/data#Medication_70123> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
55, NumberPatientsArm, 1280, 1283, "146", "", "<http://ctro/data#Arm_70083> <http://ctro/data#hasNumberPatientsArm> \"146\"."
106271, Precondition, 1301, 1338, "pre - trial sulphonylurea ± metformin", "", "<http://ctro/data#Population_70066> <http://ctro/data#hasPrecondition> \"pre - trial sulphonylurea ± metformin\"."
17, Sulfonylureas, 1313, 1326, "sulphonylurea", "", 
21, Metformin, 1329, 1338, "metformin", "", 
63, FastingBloodGlucose_target, 1356, 1406, "fasting glycaemic target of 4 . 0 - 6 . 0 mmol / l", "", 
159, Millimoles_per_litre, 1398, 1406, "mmol / l", "", 
68, DoseDescription, 1409, 1487, "Treatment initiation was at 10 dose steps , and maximum dose was 50 dose steps", "", "<http://ctro/data#Medication_70116> <http://ctro/data#hasDoseDescription> \"Treatment initiation was at 10 dose steps , and maximum dose was 50 dose steps\". <http://ctro/data#Medication_70144> <http://ctro/data#hasDoseDescription> \"Treatment initiation was at 10 dose steps , and maximum dose was 50 dose steps\"."
64, DoseValue, 1490, 1492, "50", "", "<http://ctro/data#Medication_70116> <http://ctro/data#hasDoseValue> \"50\"."
66, BioAndMedicalUnit, 1493, 1498, "units", "", "<http://ctro/data#BioAndMedicalUnit_70119> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Medication_70116> <http://ctro/data#hasDoseUnit> <http://ctro/data#BioAndMedicalUnit_70119>."
4, InsulinDegludec, 1499, 1515, "insulin degludec", "", "<http://ctro/data#Medication_70116> <http://ctro/data#hasDrug> <http://ctro/data#InsulinDegludec>."
65, DoseValue, 1518, 1523, "1 . 8", "", "<http://ctro/data#Medication_70144> <http://ctro/data#hasDoseValue> \"1 . 8\"."
67, mg, 1524, 1526, "mg", "", "<http://ctro/data#Medication_70144> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
7, Liraglutide, 1527, 1538, "liraglutide", "", "<http://ctro/data#Medication_70144> <http://ctro/data#hasDrug> <http://ctro/data#Liraglutide>."
163, Mean, 1557, 1561, "mean", "", "<http://ctro/data#Mean_70168> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_70166> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_70168>."
69, HbA1c, 1562, 1567, "HbA1c", "", "<http://ctro/data#Endpoint_70166> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
70, BaseLineValue, 1583, 1585, "63", "", "<http://ctro/data#Outcome_70171> <http://ctro/data#hasBaselineValue> \"63\". <http://ctro/data#Outcome_70198> <http://ctro/data#hasBaselineValue> \"63\"."
165, ConcentrationUnit, 1586, 1596, "mmol / mol", "", "<http://ctro/data#ConcentrationUnit_70169> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#ConcentrationUnit>. <http://ctro/data#Endpoint_70166> <http://ctro/data#hasBaselineUnit> <http://ctro/data#ConcentrationUnit_70169>."
75, BaseLineValue, 1599, 1604, "7 . 9", "", 
76, Percentage, 1605, 1606, "%", "", 
80, ResultMeasuredValue, 1612, 1614, "46", "", "<http://ctro/data#Outcome_70171> <http://ctro/data#hasResultMeasuredValue> \"46\"."
171, ConcentrationUnit, 1615, 1625, "mmol / mol", "", 
81, ResultMeasuredValue, 1628, 1633, "6 . 4", "", 
77, Percentage, 1634, 1635, "%", "", 
10, FixedCombDrug, 1643, 1651, "IDegLira", "", 
82, ResultMeasuredValue, 1659, 1661, "57", "", "<http://ctro/data#Outcome_70198> <http://ctro/data#hasResultMeasuredValue> \"57\"."
172, ConcentrationUnit, 1662, 1672, "mmol / mol", "", 
83, ResultMeasuredValue, 1675, 1680, "7 . 4", "", 
78, Percentage, 1681, 1682, "%", "", 
57, Placebo, 1690, 1697, "placebo", "", 
181, DiffGroupAbsValue, 1731, 1735, "- 11", "", "<http://ctro/data#DiffBetweenGroups_70225> <http://ctro/data#hasDiffGroupAbsValue> \"- 11\"."
180, ConcentrationUnit, 1736, 1746, "mmol / mol", "", 
85, ConfIntervalDiff, 1749, 1768, "95 % CI - 13 ; - 10", "", "<http://ctro/data#DiffBetweenGroups_70225> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 13 ; - 10\"."
100, DiffGroupAbsValue, 1774, 1782, "- 1 . 02", "", 
79, Percentage, 1783, 1784, "%", "", 
86, ConfIntervalDiff, 1787, 1814, "95 % CI - 1 . 18 ; - 0 . 87", "", 
87, PvalueDiff, 1819, 1830, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_70225> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
88, HbA1c_target, 1839, 1878, "HbA1c target of 53 mmol / mol ( < 7 % )", "", "<http://ctro/data#Endpoint_70234> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c_target>."
188, ConcentrationUnit, 1858, 1868, "mmol / mol", "", 
189, Percentage, 1875, 1876, "%", "", 
89, PercentageAffected, 1895, 1901, "79 . 2", "", "<http://ctro/data#Outcome_70239> <http://ctro/data#hasPercentageAffected> \"79 . 2\"."
12, FixedCombDrug, 1927, 1935, "IDegLira", "", 
90, PercentageAffected, 1945, 1951, "28 . 8", "", "<http://ctro/data#Outcome_70266> <http://ctro/data#hasPercentageAffected> \"28 . 8\"."
58, Placebo, 1961, 1968, "placebo", "", 
92, PvalueDiff, 2037, 2048, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_70293> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
197, Mean, 2053, 2057, "Mean", "", "<http://ctro/data#Mean_70304> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_70302> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_70304>."
198, BodyWeight, 2058, 2064, "weight", "", "<http://ctro/data#Endpoint_70302> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
94, Increment, 2078, 2083, "0 . 5", "", "<http://ctro/data#Outcome_70307> <http://ctro/data#hasChangeValue> \"0 . 5\"."
95, Kg, 2084, 2086, "kg", "", "<http://ctro/data#Endpoint_70302> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
11, FixedCombDrug, 2092, 2100, "IDegLira", "", 
98, Reduction, 2106, 2111, "1 . 0", "", "<http://ctro/data#Outcome_70334> <http://ctro/data#hasChangeValue> \"1 . 0\"."
96, Kg, 2112, 2114, "kg", "", 
59, Placebo, 2120, 2127, "placebo", "", 
99, DiffGroupAbsValue, 2161, 2167, "1 . 48", "", "<http://ctro/data#DiffBetweenGroups_70361> <http://ctro/data#hasDiffGroupAbsValue> \"1 . 48\"."
97, Kg, 2168, 2170, "kg", "", 
101, ConfIntervalDiff, 2173, 2196, "95 % CI 0 . 90 ; 2 . 06", "", "<http://ctro/data#DiffBetweenGroups_70361> <http://ctro/data#hasConfIntervalDiff> \"95 % CI 0 . 90 ; 2 . 06\"."
102, PvalueDiff, 2201, 2212, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_70361> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
103, Hypoglycemia, 2227, 2240, "hypoglycaemia", "", "<http://ctro/data#Endpoint_70370> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia>. <http://ctro/data#Endpoint_70429> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Hypoglycemia>."
104, PercentageAffected, 2253, 2259, "41 . 7", "", "<http://ctro/data#Outcome_70375> <http://ctro/data#hasPercentageAffected> \"41 . 7\"."
105, PercentageAffected, 2264, 2270, "17 . 1", "", "<http://ctro/data#Outcome_70402> <http://ctro/data#hasPercentageAffected> \"17 . 1\"."
13, FixedCombDrug, 2276, 2284, "IDegLira", "", 
60, Placebo, 2291, 2298, "placebo", "", 
106172, ResultMeasuredValue, 2353, 2358, "3 . 5", "", "<http://ctro/data#Outcome_70434> <http://ctro/data#hasResultMeasuredValue> \"3 . 5\"."
106173, ResultMeasuredValue, 2362, 2367, "1 . 4", "", "<http://ctro/data#Outcome_70461> <http://ctro/data#hasResultMeasuredValue> \"1 . 4\"."
218, BioAndMedicalUnit, 2368, 2404, "events / patient - years of exposure", "", "<http://ctro/data#BioAndMedicalUnit_70432> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_70429> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_70432>."
106174, DiffGroupRelValue, 2428, 2434, "3 . 74", "", "<http://ctro/data#DiffBetweenGroups_70488> <http://ctro/data#hasDiffGroupRelValue> \"3 . 74\"."
109, ConfIntervalDiff, 2437, 2460, "95 % CI 2 . 28 ; 6 . 13", "", "<http://ctro/data#DiffBetweenGroups_70488> <http://ctro/data#hasConfIntervalDiff> \"95 % CI 2 . 28 ; 6 . 13\"."
110, PvalueDiff, 2465, 2476, "P < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_70488> <http://ctro/data#hasPvalueDiff> \"P < 0 . 001\"."
62, FixedCombDrug, 2481, 2489, "IDegLira", "", 
111, EndPointDescription, 2534, 2556, "serious adverse events", "", "<http://ctro/data#EndPointDescription_70498> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_70497> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_70498>."
112, ResultMeasuredValue, 2562, 2568, "20 . 3", "", "<http://ctro/data#Outcome_70502> <http://ctro/data#hasResultMeasuredValue> \"20 . 3\"."
113, ResultMeasuredValue, 2573, 2578, "8 . 0", "", "<http://ctro/data#Outcome_70529> <http://ctro/data#hasResultMeasuredValue> \"8 . 0\"."
222, BioAndMedicalUnit, 2579, 2614, "per 100 patient - years of exposure", "", "<http://ctro/data#BioAndMedicalUnit_70500> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_70497> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_70500>."
14, FixedCombDrug, 2620, 2628, "IDegLira", "", 
61, Placebo, 2633, 2640, "placebo", "", 
15, FixedCombDrug, 2721, 2729, "IDegLira", "", 
115, ConclusionComment, 2721, 2873, "IDegLira can be used in people uncontrolled with sulphonylurea ± metformin to improve efficacy with a safety profile in line with previous DUAL trials .", "", "<http://ctro/data#ClinicalTrial_70050> <http://ctro/data#hasConclusionComment> \"IDegLira can be used in people uncontrolled with sulphonylurea ± metformin to improve efficacy with a safety profile in line with previous DUAL trials .\"."
24, Sulfonylureas, 2770, 2783, "sulphonylurea", "", 
25, Metformin, 2786, 2795, "metformin", "", 
116, PMID, 2951, 2959, "27589252", "", "<http://ctro/data#Publication_70043> <http://ctro/data#hasPMID> \"27589252\"."
